The medical cannabis market in Maryland is flourishing, with sales rapidly moving toward half a billion dollars a year.

Experts credit that success, in part, to clear and transparent regulations – and regulators who have balanced compliance with patient access.

But a huge lingering issue looms: litigation and investigations into a 2019 licensing round that was designed to boost diversity in the industry.

With huge state funding shortages because of the massive impact of the coronavirus crisis, Maryland is under increasing pressure to legalize recreational marijuana, said Bridget Zayat,Hill– a Hoban Law Group attorney who is licensed to practice in Maryland, New Jersey and Pennsylvania.

But, she cautioned, “I think there are issues absolutely that have to be addressed, including minority ownership.”

Read the full article on Marijuana Business Daily